4 recent moves from MD Anderson

Here are five moves reported by Becker’s about the University of Texas MD Anderson Cancer Center since Jan. 10: 

Advertisement

1. The center was awarded $31.7 million from the Cancer Prevention and Research Institute of Texas, the center said Feb. 16.

2. The center extended its partnership with Phoenix-based Banner Health for another 10 years, the cancer center said Feb. 15. 

3. The center announced a research collaboration with Planegg, Germany-based Eisbach Bio GmbH Jan. 19 dedicated to discovering and developing precision oncology drugs that target synthetic lethal engines.

4. A personalized lung cancer risk assessment, including a blood test developed by MD Anderson researchers, identified 9.2 percent more lung cancer cases for screening and reduced referral to screening among non-cases by 13.7 percent, a study published Jan. 7 in the Journal of Clinical Oncology found.

At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.

Advertisement

Next Up in Oncology

Advertisement